Digestive Diseases and Sciences

, Volume 40, Issue 3, pp 495–502 | Cite as

Endotoxin-resistant mice are protected from PAF-induced bowel injury and death role of TNF, complement activation, and endogenous PAF production

  • Xiaoming Sun
  • Michael S. Caplan
  • Yueying Liu
  • Wei Hsueh
Intestinal Disorders, Inflammatory Bowel Disease, Immunology, And Microbiology


C3H/HeJ (endotoxin-resistant) mice have been used widely in biological research. However, the mechanism of endotoxin (LPS) resistance is only partially understood. In this study, we first investigated the differences in response to PAF, a mediator of endotoxin shock, between normal and C3H/HeJ mice. We found that in control mice, PAF (2.5 µg/kg) caused shock, hemoconce tration, complement activation, intestinal hypoperfusion, and necrosis with 75% mortality, whereas all C3H/HeJ mice survived, without complement activation or intestinal injury, and manifesting only mild hypotension and hemoconcentration. PAF also caused elevated serum TNF-α in some control mice but not in C3H/HeJ mice. We also observed that PAF induces endogenous PAF production and intestinal phospholipase A2 activation in normal mice, whereas PAF production and phospholipase A2 are suppressed in C3H/HeJ mice. The low endogenous PAF production may account, at least in part, for the resistance to LPS and PAF of C3H/HeJ mice.

Key Words

PAF (platelet-activating factor, paf-acether) intestine endotoxin TNF (tumor necrosis factor) 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Benveniste J, Henson PM, Cochrane CG: Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils and a platelet-activating factor. J Exp Med 136:1356–1377, 1972PubMedGoogle Scholar
  2. 2.
    Old LJ: Tumor Necrosis Factor (TNF). Science 230:630–632, 1985PubMedGoogle Scholar
  3. 3.
    Beutler B, Cerami A: Tumor necrosis, cachexia, shock and inflammation: a common mediator. Annu Rev Biochem 57:505–518, 1988PubMedGoogle Scholar
  4. 4.
    Mathison JC, Wolfson E, Ulevitch RJ: Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest 81:1925–1937, 1988PubMedGoogle Scholar
  5. 5.
    Bussolino S, Porcellin MG, Varese L, Bosia A: Intravascular release of Platelet-activating factor in children with sepsis. Thromb Res 48:619–620, 1987PubMedGoogle Scholar
  6. 6.
    Marks JD, Marks CB, Luce JM, Montgomery AB, Turner J, Metz CA, Murray JF: Plasma tumor necrosis factor in patients with septic shock. Am Rev Respir Dis 141:94–97, 1990PubMedGoogle Scholar
  7. 7.
    Chang SW, Feddersen CO, Henson PM, Voelkel NF: Platelet-activating factor mediates hemodynamic changes and lung in endotoxin-treated rat. J Clin Invest 79:1498–1509, 1987PubMedGoogle Scholar
  8. 8.
    McManus LM, Hanahan DJ, Demopoulos CA, Pinckard RN: Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit. J Immunol 124:2919–2924, 1980PubMedGoogle Scholar
  9. 9.
    Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ III, Zentella A, Albert JD, Shires T, Cerami A: Shock and tissue injury induced by recombinant human cachectin. Science 234:470–474, 1986PubMedGoogle Scholar
  10. 10.
    Handley DA: Platelet-activating factor as a mediator of endotoxin-related diseases.In Platelet-Activating Factor in Endotoxin and Immune Disease. DA Handley, RN Saunders, WJ Houlihan, JC Tomesch (eds). New York, Dekker, 1990, pp 451–495Google Scholar
  11. 11.
    Beutler B, Milsark IW, Cerami AC: Passive immunization against cachectin/tumor necrosis factor protects mice from the lethal effects of endotoxin. Science 229:869–871, 1985PubMedGoogle Scholar
  12. 12.
    Gonzalez-Crussi F, Hsueh W: Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin. Am J Pathol 112:127–135, 1983PubMedGoogle Scholar
  13. 13.
    Sun X, Hsueh W: Platelet-activating factor produces shock,in vivo complement activation, and tissue injury in mice. J Immunol 147:509–514, 1991PubMedGoogle Scholar
  14. 14.
    Sun XM, Hsueh W: Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. J Clin Invest 81:1328–1331, 1988PubMedGoogle Scholar
  15. 15.
    Hsueh W, Sun X, Rioja LN, Gonzalez-Crussi F: The role of the complement system in shock and tissue injury induced by tumour necrosis factor and endotoxin. Immunology 70:309–314, 1990PubMedGoogle Scholar
  16. 16.
    Hsueh W, Gonzalez-Crussi F, Arroyave JL: Platelet-activating factor: An endogenous mediator for bowel necrosis in endotoxemia. FASEB J 1:403–405, 1987PubMedGoogle Scholar
  17. 17.
    Snyder F: Biochemistry of platelet-activating factor: A biologically active phosphoglyceride. Proc Soc Exp Biol Med 190:125–135, 1989PubMedGoogle Scholar
  18. 18.
    Zhang C, Hsueh W, Caplan MS, Kelly A: Platelet activating factor-induced shock and intestinal necrosis in the rat: role of endogenous platelet-activating factor and effect of saline infusion. Crit Care Med 19:1067–1072, 1991PubMedGoogle Scholar
  19. 19.
    Sun X, Caplan MS, Hsueh W: TNF and endotoxin synergistically activate intestinal phospholipase A2 in mice, role of endogenous PAF and effect of exogenous PAF. Gut 35:215–219, 1994PubMedGoogle Scholar
  20. 20.
    Watson J, Kelly K, Largen M, Taylor BA: The genetic mapping of a defective LPS response gene in C3H/HeJ mice. J Immunol 120:422–424, 1978PubMedGoogle Scholar
  21. 21.
    Glode LM, Jacques A, Mergenhagen SE, Rosenstrich DL: Resistance of macrophages from C3H/HeJ mice to thein vitro cytotoxic effects of endotoxin. J Immunol 119:162–166, 1977PubMedGoogle Scholar
  22. 22.
    Rosenstreich DL, Vogel SN, Jacques AR, Oppenheim JJ: Macrophage sensitivity to endotoxin: Genetic control by a single codominant gene. J Immunol 121:1664–1670, 1978PubMedGoogle Scholar
  23. 23.
    Apte RN, Ascher O, Pluznik DH: Genetic analysis of generation of serum interferon by bacterial lipopolysaccharide. J Immunol 119:1898–1902, 1977PubMedGoogle Scholar
  24. 24.
    Apte RN, Pluznik DH: Genetic control of lipopolysaccharide induced generation of serum colony stimulation factor and proliferation of splenic granulocyte/macrophage precursor cells. J Cell Physiol 89:313–323, 1976PubMedGoogle Scholar
  25. 25.
    Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A: Control of cachetin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance. Science 232:977–980, 1986PubMedGoogle Scholar
  26. 26.
    Sun XM, Hsueh W, Torre-Amione G: Effects ofin vivo “priming” on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor. Am J Pathol 136:949–956, 1990PubMedGoogle Scholar
  27. 27.
    Folch J, Lees M, Sloane Stanley GH: A simple method for isolation and purification of total lipides from animal tissue. J Biol Chem 226:497–509, 1957PubMedGoogle Scholar
  28. 28.
    MacKendrick W, Caplan MS, Hsueh W: Platelet activating factor levels in enterally fed premature infants. Biol Neonate 64:89–95, 1993PubMedGoogle Scholar
  29. 29.
    Suga K, Kawasaki T, Blank ML, Snyder F: An arachidonoyl (polyenoic)-specific phospholipase A2 activity regulates the synthesis of platelet-activating factor in granulocytic HL-60 cells. J Biol Chem 265:12363–12371, 1990PubMedGoogle Scholar
  30. 30.
    Chilton FH, Ellis JM, Olson SC, Wykle RW: 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes. J Biol Chem 259:12014–12019, 1984PubMedGoogle Scholar
  31. 31.
    Hsueh W, Gonzalez-crussi F, Arroyave JL: Release of leukotriene C4 by isolated, perfused rat small intestine in response to platelet activating factor. J Clin Invest 78:108–114, 1986PubMedGoogle Scholar
  32. 32.
    Rose JK, Debs RA, Philip R, Ruis NM, Valone FH: Selective activation of human monocytes by the platelet-activating factor analog 1-O-hexadecyl-2-methyl-sn-glycero-3-phosphorylcholine. J Immunol 144:3513–3517, 1990PubMedGoogle Scholar
  33. 33.
    Poubelle PE, Gingras D, Demers C, Dubois C, Harbour D, Grassi J, Rola-Pleszczynski M: Platelet-activating factor (PAF-acether) enhances the concomitant production of tumour necrosis factor-alpha and interleukin-1 by subsets of human monocytes. Immunology 72:181–187, 1991PubMedGoogle Scholar
  34. 34.
    Strieter RM, Remick DG, Ward PA, Spengler RN, Lynch JP, Larrick J, Kunkel SL: Cellular and molecular regulation of tumor necrosis factor-α production by pentoxifylline. Biochem Biophys Res Commun 155:1230–1236, 1988PubMedGoogle Scholar
  35. 35.
    Hsueh W, Sun XM, Rioja LN, Gonzalez-Crussi F: The role of the complement system in shock and tissue injury induced by tumor necrosis factor and endotoxin. Immunology 70:309–314, 1990PubMedGoogle Scholar
  36. 36.
    Llausas-Magana E, Hsueh W, Arroyave CM, Arroyave JL, Torre-Amione G, Gonzalez-Crussi F: Cobra venom factor, an activator of the complement system, enhances the bowel necrosis induced by platelet-activating factor. Immunopharmacology 15:31–38, 1988PubMedGoogle Scholar
  37. 37.
    Ding A, Sanchez E, Nathan CF: Taxol shares the ability of bacterial lipopolysaccharide to induce tyrosine phosphorylation of microtubule-associated protein kinase. J Immunol 151:5596–5602, 1993PubMedGoogle Scholar
  38. 38.
    Schiffrin EJ, Trop M, Schroeder S, Carter EA: Platelet-activating factor induces intestinal necrosis, but not septic shock, in germ-free and specific-pathogen-free rodents. Burns 17:276–278, 1991PubMedGoogle Scholar
  39. 39.
    Chang TW, Wu MH, Yang YJ: Blood levels of platelet-activating factor in endotoxin-sensitive and endotoxin-resistant mice during endotoxemia. J Formosan Med Assoc 91:1133–1137, 1992PubMedGoogle Scholar
  40. 40.
    Tan X-D, Sun XM, Gonzalez-Crussi FX, Gonzalez-Crussi F, Hsueh W: PAF and TNF increase the precursor of NF-kappa B p50 mRNA in mouse intestine: Quantitative analysis by competitive PCR. Biochim Biophys Acta 1215:157–162, 1994PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1995

Authors and Affiliations

  • Xiaoming Sun
    • 1
    • 2
  • Michael S. Caplan
    • 1
    • 2
  • Yueying Liu
    • 1
    • 2
  • Wei Hsueh
    • 1
    • 2
  1. 1.From the Department of PathologyChildren's Memorial HospitalUSA
  2. 2.Department of Pediatrics, Evanston HospitalNorthwestern University Medical School

Personalised recommendations